We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Comments: FDA Should Revise Trials, Criteria for Drug Codevelopment
Comments: FDA Should Revise Trials, Criteria for Drug Codevelopment
March 2, 2011
Drugmakers have asked the FDA to broaden the scope of its draft guidance on codevelopment to allow use of drug combinations under a wider set of circumstances.